Previous reports raised question as to whether 8-chloro-cyclic adenosine 3,5-monophosphate (8-ClcAMP) is a prodrug for its metabolite, 8-Cl-adenosine which exerts growth inhibition in a broad spectrum of cancer cells. The present study was carried out to clarify overall cellular affects of 8-Cl-cAMP and 8-Cl-adenosine on SK-N-DZ human neuroblastoma cells by systematically characterizing gene expression using radioactive human cDNA microarray. 
Introduction
8-Cl-adenosine, dephosphorylated metabolite of antineoplastic agent 8-Cl-cAMP has a growth-inhibitory effect, which is produced from 8-Cl-cAMP by the action of serum phosphodiesterase and 5-nucleotidase activity ( Figure. 1) (Taylor et al., 1990; Lange-Carter et al., 1993; Halgren et al., 1998) . 8-Cl-cAMP, a siteselective cAMP analogue, exhibits growth inhibition in a broad spectrum of cancer cell lines. However, its mechanism of action remains unelucidated. One possible mode of action is to induce cytotoxicity by acting as competitive inhibitor in biochemical pathway involving cAMP-dependent protein kinase [protein kinase A (PKA)] (Cho-Chung, 1989; Cho-Chung et al., 1995; Noguchi et al., 1998) . PKA is a serine/threonine protein kinase that is activated by cAMP. Two isozymes of PKA, PKA-I and PKA-II, are distinguished by the association of type R subunit (R) or type R subunit (R) with common C subunits, respectively. Four different R subunits-RIa, RIb, RIIa, and RIIb-have been identified (Taylor et al., 1990) . Expression of the PKA RIa subunit is correlated with active cell growth and transformation, and increased in various human tumors and cell lines. Furthermore, overexpression of the PKA RIa subunit is correlated with malignancy and poor prognosis in cancer patients (Miller et al., 1993a; Miller et al., 1993b; Simpson et al., 1996; Miller et al., 1997) . In contrast, a high level of Rb is correlated with growth arrest and differentiation (Cho-Chung, 1990 ). Cancer cells treated with 8-Cl-cAMP showed a decrease of Ra and an increase of Rb, leading to inhibition of cancer cell growth (Ally et al., 1988; Ciardiello et al., 1990; Rohlff et al., 1993) .
The mechanism of 8-Cl-cAMP action is not yet clarified as to whether it is a prodrug for its metabolite, 8-Cl-adenosine. On the one side, 8-Cl-cAMP exerts its growth-inhibitory effect by binding to PKA in a competitive manner against cAMP (Rohlff et al., 1993; Noguchi et al., 1998) and on the other side, the effect of 8-Cl-cAMP is at least in part due to its metabolite 8-Cl-adenosine. Furthermore, the anticancer effect of 8-Cl-cAMP has been suggested to be independent of residual activity of PKA or concentration of cAMP (Lange-Carter et al., 1993; Cummings et al., 1996; Langefeld et al., 1997; Halgren et al., 1998; Carlson et al., 2001; Yin et al., 2001) .
In order to evaluate the molecular portrait of anticancer actions of 8-Cl-adenosine versus 8-Cl-cAMP, we have selected human cDNA microarray comprised of 2,304 nonredundant human clones to examine whole spectrum of genes affected by both drugs. The microarray-based genomic survey is one of the highthroughput well known approaches, and has allowed parallel studies on expression patterns of thousands of genes (Schena et al., 1995; Duggan et al., 1999; Konu et al., 2001; Vawter et al., 2001) . In the present study, we investigated genome-wide expression profiling under the treatment of 8-Cl-adenosine or 8-Cl-cAMP as compared to untreated control. As a cancer cell model, SK-N-DZ human neuroblastoma cell line was chosen, because it has higher concentration of PKA than other types of cancer cells (Cho et al., 2000) .
Materials and Methods
Cell culture and RNA preparation SK-N-DZ cells (ATCC #CRL-2149) grown in RPMI 1640 medium with 10% fetal bovine serum, 50 units/ml penicillin, 500 µg/ml streptomycin, and 1 mM glutamine (GIBCO) were seeded at 5x10 5 cells per dish at humidified atmosphere of 5% CO 2 at 37 o C. Cells were counted on a Coulter Counter, and were treated with 5 µM 8-Cladenosine (Biology Life Science Institute, Bremen, Germany) or 8-Cl-cAMP (National Cancer Institute, Drug Synthesis and Chemistry Branch, Bethesda, MD. USA) for 24 h, respectively. Total RNA was prepared by using RNeasy Midi Kit (Qiagen, Chatsworth, CA, USA).
Human cDNA microarray
A human cDNA microarray was primarily derived from a commercially available master set of approximately 15,000 human verified-sequences (Research Genetics, Inc.). The 15,000 human cDNA clone set was sorted for a list of genes (2,304 elements) representing families such as differentiation, development, proliferation, transformation, cell cycle progression, immune response, transcription and translation factors, oncogenes, and molecules involved in cell growth and maintenance. PCR-amplified cDNAs were spotted on nylon membranes. The general methodology of arraying is based on the procedures of DeRisi et al. (1996) .
cDNA Radiolabeling
Total RNAs prepared from SK-N-DZ cells treated with 8-Cl-adenosine or 8-Cl-cAMP and untreated control cells were used to synthesize 33 P-labeled cDNAs by reverse transcription. Briefly, 3~10 µg RNA were labeled in a reverse transcription reaction containing 5X first strand PCR buffer, 1 µg of 24-mer poly dT primer, 4 µl of 20 mM each dNTP excluding dCTP, 4 µl of 0.1 M DTT, 40 U of RNase inhibitor, 6 µl of 3000 Ci/mmol α-33 P dCTP to a final volume of 40 µl. The mixture was heated at 65 o C for 5 min, followed by incubation at 42 o C for 3 min. Two µl (specific activity: 200,000 U/ml) of Superscript reverse transcriptase (Life Technologies) was then added and the samples were incubated for 30 min at 42 o C, followed by the addition of 2 µl of Superscript reverse transcriptase and another 30 min of incubation. Five µl of 0.5 M EDTA was added to chelate divalent cations. After the addition of 10 µl of 0.1 M NaOH, the samples were incubated at 65 o C for 30 min to hydrolyze remaining RNA. Following the addition of 25 µl of 1 M Tris (pH 8.0), the samples were purified using Bio-Rad 6 purification columns (Hercules, CA, USA). This resulted in 5x10 6 to 3x10 7 cpm per reaction ).
Hybridization and Scanning
cDNA microarrays were pre-hybridized in hybridization buffer containing 4.0 ml Microhyb (Research Genetics), 10 µl of 10 µg/ml human Cot 1 DNA (Life Technologies), and 10 µl of 8 mg/ml poly dA (Pharmacia, NJ). Both Cot 1 and poly dA were denatured at 95 o C for 5 min prior to use. After 4 h of pre-hybridization at 42 o C, approximately 10 7 cpm/ml of heat-denatured (95 o C, 5 min) probes were added and incubation was continued for 17 h at 42 o C. Hybridized arrays were washed three times in 2X SSC and 0.1% SDS for 15 min at room temperature. The microarrays were exposed to phosphorimager screens for 1-5 days, and the screens were then scanned in a FLA-8000 (Fuji Photo Film Co) at 50 µm resolution ).
Data analysis
Microarray images were trimmed and rotated for further analysis using L-Processor (Fuji Photo Film Co). Gene expression of each microarrays was captured by the intensity of each spot produced by radioactive isotopes. Pixels per spot were counted by Arrayguage (Fuji Photo Film Co) and were exported to Microsoft Excel (Microsoft, Seattle, WA, USA). The data were normalized with Z transformation to obtain Z scores by subtracting each average of gene intensity and dividing with each standard deviation. Z scores provide each of 2,304 genes with the distance from the average intensity and were expressed in units of standard deviation. Thus, each Z score provides flexibility to compare different sets of microarray experiments by adjusting differences in hybridization intensities.
Gene expression difference as compared to untreated control cells was calculated by comparing the Z score differences (Z differences) among the same genes. This facilitates to compare each gene that had been up-or downregulated as compared to the control cells. Z differences were calculated first by subtracting Z scores of the control from each Z score of the samples. These differences were normalized again to distribute their position by subtracting the average Z difference and dividing with the standard deviation of the Z differences. These distributions represent the Z ratio value, and provide the efficiency for comparing each microarray experiment . Spotfire produced scatter plots of intensity values. (Spotfire, Inc., Cambridge, MA) (Tanaka et al., 2000) . Cluster analysis was performed on Z-transformed microarray data by using two programs available as shareware from Michael Eisens laboratory (http:// rana.lbl.gov). Clustering of changes in gene expression was determined by using public domain Cluster based on pair wise complete-linkage cluster analysis (Eisen et al., 1998) .
Western analysis

SK-N-DZ cells were seeded at a density of 1×10
6 cells/ 100-mm plate and treated with 8-Cl-adenosine or 8-ClcAMP (5 µM each) for 12 or 24 h. Cells were washed twice with ice-cold PBS, lysed in buffer (20 mM Tris/HCl, 100 µM NaCl, 5 mM MgCl 2 , 1% NP-40, 0.5% sodium deoxycholate, 100 µM pepstatin, 100 µM antipain, 100 µM chymostatin, 10 µg/ml leupeptin, 0.5 µM phenylmethylsulfonyl fluoride, 5 mg/ml trypsin inhibitor, and 1 mM benzamidine, pH 7.5), and placed on ice for 15 min. Protein concentration was determined by the Bradford assay using the Bio-Rad protein assay kit (Bio-Rad). Cell extracts were subjected to SDS-PAGE, and Western analysis was performed according to the described method (Srivastava et al., 1999 
Results and Discussion
Microarray reproducibility
To assess the reliability of microarray technique used, we calculated microarray reproducibility between duplicates. The duplicate genetic elements for each microarray resulted in two separate Z normalizations and an average Z score for each gene. The scatter plot for Z scores in untreated control and 8-Cl-adenosine-or 8-Cl-cAMP-treated cells showed R 2 across duplicates of 0.81, 0.83, and 0.95, respectively ( Figure. 2). A perfect relationship between duplicates would be a slope of 1. The average coefficient of variation for duplicate Z scores within each microarray was below 20% approximately, indicating a high reliability of our microarray data.
Expression profiles between 8-Cl-adenosine-and 8-Cl-cAMP-treated SK-N-DZ cells
The mechanism of 8-Cl-cAMP action has been controversial among some academics that begun more than a decade ago (Ally et al., 1988; Ciardiello et al., 1990; Rohlff et al., 1993) . One of the possible mechanisms has been suggested to be through direct modulation of PKA activity and the other via its metabolite, 8-Cladenosine. In order to identify the genomic mechanism , microarray hybridization patterns were found to be highly consistent between the samples. A perfect relationship between samples would be a slope of 1. specific for anticancer activity of 8-Cl-adenosine or 8-ClcAMP by using DNA microarray technology, three independent experiments were performed and a representative one was selected. The expression levels of ≈100 cDNA, representing ≈8% of the total DNA elements on the array, were found to be altered (≥2-fold up-regulated or down-regulated as compared to untreated control) in 8-Cl-adenosine-and 8-Cl-cAMP-treated cells, respectively. The changes ranged from -7.3 fold to +7.8 fold in 8-Cl-adenosine-treated cells, and -6.29 fold to +8.1 fold in 8-Cl-cAMP-treated cells. There were 42 upregulated and 59 down-regulated genes in 8-Cladenosine-treated cells and 65 up-regulated and 41 down-regulated genes in 8-Cl-cAMP-treated cells.
Genes showing highly altered expression levels in treated cells were aligned in the order of the magnitude of altered expression in 8-Cl-adenosine-treated cells (Table 1 ). The expression profile of 8-Cl-adenosine-or 8-Cl-cAMP-treated cells exhibited a partial overlap with each other; the same set of down-regulated genes and different sets of up-regulated genes (except a few genes) between the two samples on the basis of Z ratio. A scatter plot revealed a single type of down-regulation but a bifurcated type of up-regulation, confirming the result ( Figure. 3). Representative genes differentially or coincidentally regulated are presented in Table 2 . These results indicated that two drugs shared some common genomic pathways leading to the down-regulation of certain genes, but used distinct pathways for most upregulated gene clusters involved in different categories of cellular processes. Based on the findings, it could be hypothesized that the anti-cancer activities of cAMP were due to direct modulation of PKA independent of 8-Cl-adenosine, or via its metabolite, 8-Cl-adenosine, which explains the striking overlaps between down-regulated genes by the two drugs, or a concerted action of the both pathways.
Differential gene up-regulation by 8-Cl-adenosine and 8-Cl-cAMP detected by microarray was verified by Western analysis
To confirm the differential up-regulation of genes by 8-Cl-adenosine and 8-Cl-cAMP identified by microarray, Western blotting of two differentially regulated genes was performed to examine the direction of changes as well as the magnitude of altered expression (Figure. (Table 1) .
Molecular profiling of anticancer effects of 8-Cladenosine and 8-Cl-cAMP on SK-N-DZ cells
The anticancer activities of 8-Cl-adenosine and 8-ClcAMP have been well known in a variety of cancer cells, and phase I clinical studies have been performed against solid tumors with some evidence of clinical response (Halgren et al., 1998) . Nevertheless, their precise molecular mechanisms of actions are not yet fully understood. To obtain a molecular portrait of these anticancer activities, we used a hierarchical clustering algorithm to group genes on the basis of similarity in their expression patterns (Eisen et al., 1998) , and the data are presented in a matrix format ( Figure. 5) . Each row represents all of the hybridization results for a single DNA element of the array, and each column represents the expression levels for all genes in a single hybridization sample. The expression level of each gene is visualized in color, relative to its median expression level across all samples. Red represents an expression greater than the mean and green represents an expression less than the mean, and the intensity of the color denotes the degree of deviation from the mean. Black represents median expression level. Distinct samples representing similar gene patterns from control cells are aligned in adjacent rows. Included in this map are samples from untreated control and 8-Cl-adenosine-or 8-Cl-cAMP-treated SK-N-DZ cells. Coordinately expressed genes were grouped into clusters, which we named on Growth factor Neuron-specific signal transduction Reversible hydratation of carbon dioxid Regulation of cellular growth and/or development the basis of the cellular process in which the component genes participate.
The clustergram revealed that 8-Cl-adenosine treatment up-regulated clusters of genes involved in differentiation and development, and down-regulated ones involved in proliferation and transformation, as compared to untreated control cells (Table 1, Figure. 5 ). The differentiation cluster was characterized by the prevalence of genes encoding developmental proteins (human LIM protein MLP, connexin 26 and neogenin), genes encoding cytoskeleton (neurofilament triplet L protein) and cell cycle proteins (p21 WAF1/CIP1 and proteasome subunit z). Some immune molecules were also up-regulated, including H.sapiens RFXAP, natural killer cells protein 4 and M130. LIM protein may be involved in specification and maintenance of differentiated phenotypical properties of some neurons (Thor et al., 1991) and an essential regulator of myogenic differentiation (Arber et al., 1994) . Connexin 26 is expressed in normal human mammary epithelial cells but not in mammary tumor cell lines (Lee et al., 1992) , and has an essential role during an early stage of murine development (Gabriel et al., 1998) . Neogenin is a tumor suppressor gene DCCrelated protein, and believed to be involved in early differentiation of nervous system (Vielmetter et al., 1997) . Neurofilament triplet L protein is the component of neuronal cytoskeleton found in neurons of both the central and peripheral nervous systems (Carpenter and Wallace, 1996) , and the up-regulation of its expression can be regarded as evidence of differentiation or reverse transformation of neuronal cells. P21 WAF1/CIP1 is a cell cycle inhibitor acting by inhibiting cyclin/CDKs (Carlson et al., 2001; Draus et al., 2001 ; Lee et al., 2002). Proteasomes degrade protein-ubiquitin conjugates in an ATP-dependent reaction, and are involved in cell cycle control and in early steps of the immune response (Petit et al., 1997) . RFXAP is critical to the expression of MHC class II genes and plays an ancillary role in the transcriptional control of MHC class I genes (Nagarajan et al., 2000) . Natural killer cells protein 4 encodes a product common to the activation pathways of both natural killer (NK) cells and T cells (Dahl et al., 1992) . M130 is a macrophage scavenger receptor, and not expressed in any cancer cells except mesothelioma where asbestos bound to the scavenger receptors (Frank et al., 1998) . The coordinate up-regulation of the above genes most likely promotes differentiation and reverse transformation.
In the proliferation and transformation clusters, genes encoding proteins involved in proliferation or transformation-related signal transduction (transforming growth factor-b superfamily protein, stac, DYRK2 and LCR1 homolog), malignancy (urokinase-type plasminogen activator, neutrophil gelatinase-associated lipocalin), transcription (transcription factor 12, general transcription factor IIF/polypeptide 1), translation (DYRK2) and nucleic acid metabolism (dihydropyridine dehydrogenase) were preferentially down-regulated by both 8-Cl-adenosine and 8-Cl-cAMP with a similar magnitude of altered expression (Table 1, Figure. 5 ). Interestingly, the most profoundly down-regulated gene in SK-N-DZ cells by the two drugs was transforming growth factor-β (TGF-β). TGF-β has a multifunctional role in tumorigenesis, acting as a tumor suppressor as well as a tumor promoter by stimulating immunosuppression, angiogenesis and synthesis of extracellular matrix (Heldin et al., 1997) . Further study is in need on the involvement of TGF-β down-regulation in the up-regulation of some immune molecules [natural killer cells protein 4 precursor (2.29 fold by 8-Cl-adenosine, 2.80 fold by 8-Cl-cAMP), RFXAP (3.96, 0.17)] and down-regulation of some extracellular matrix proteins [cartilage linking protein 1 (-3.08, -3.06), laminin B1 (-2.96, -2.30), collagen type V alpha 1 (-2.55, -2.52), collagen type XV alpha 1 (-2.50, -1.39)] observed in the present experiment. Among the highly down-regulated molecules, stac is likely involved in neuron-specific signal transduction (Suzuki et al., 1996) . DYRK2 is a member of the dual specificity tyrosine phosphorylated and regulated kinase group. A concerted action of DYRK2 and glycogen synthase kinase-3 regulates translation initiation factor eIF2B, which is involved in switching on overall protein synthesis (Campbell and Proud, 2002) . LCR1 is a Gprotein-coupled receptor, which likely influences neuronal function at the time after maturation of brain (Wong et al., 1996) . Urokinase-type plasminogen activator forms part of an important enzymatic system that degraded the extracellular matrix in process of invasion and metastasis, thereby having a strong clinical value in predicting prognosis and survival of cancer patients (Schmitt et al., 2000; Nieto-Rodriquez et al., 2001) . Neutrophil gelatinase-associated lipocalin appears to be induced in epithelial cells under special conditions such as malignancy and inflammation (Nielsen et al., 1996; Cowland and Borregaard, 1997) . Dihydropyrimidine dehydrogenase (EC 1.3.1.2) is involved in uracil and thymine degradation, and the inhibition of the enzyme can greatly potentiate the therapeutic effectiveness of 5-fluorouracil (Rosenbaum et al., 1997) . A concomitant down-regulation of the above genes seemed to be of particular relevance to the anticancer activities of the two drugs. The suppressive effect of 8-Cl-adenosine on these gene clusters remarkably resembled that of 8-ClcAMP, indicating their use of distal common genomic pathways for the down-regulation of these genes. Furthermore, the altered expression profile generated by 8-Cl-adenosine or 8-Cl-cAMP treatment would reflect true intrinsic differences between the untreated and treated cells rather than variations arising from experimental artifacts.
In summary, we performed radioactive human cDNA microarray to elucidate genomic mechanisms of anticancer activities of 8-Cl-adenosine versus 8-Cl-cAMP, which has been controversial for a long time. In the present study, the down-regulated genes by 8-Cl-adenosine treatment were closely mirrored in those by 8-Cl-cAMP. In contrast, the distinct clusters of genes were upregulated by the two drugs. Therefore, our data suggest that 8-Cl-adenosine and 8-Cl-cAMP use differential gene regulation mechanisms for their anticancer activities, however, sharing some common distal events with each other. Furthermore, we also suggest that the anti-cancer activities of 8-Cl-cAMP are derived from both direct modulation of PKA independent of its metabolite, 8-Cladenosine, and also via 8-Cl-adenosine which explains the striking overlaps among the down-regulated genes by the two drugs. Additionally, 8-Cl-adenosine specifically up-regulated expression of the differentiation and development clusters, and preferentially down-regulated the proliferation and transformation clusters, thereby providing a new level of understanding of the genomewide mechanism underlying its anticancer activity.
Finally, genome-wide expression profiling using human cDNA microarray has been proven to be an efficient technology to evaluate the genomic mechanism of closely related cancer therapeutics, such as 8-Cladenosine and 8-Cl-cAMP, and facilitate the development of new chemotherapeutic combinations based on the dynamic molecular actions of drugs. 00-GN-01-002) and by National Nuclear R and D program from the Korean Ministry of Science and Technology. We especially thanks to Drs. Su-Jae Lee and Yun-Sil Lee in Laboratory of Radiation Effect, Korea Cancer Center Hospital, Seoul, Korea for their kind academic advises.
